PRESS RELEASE published on 06/14/2024 at 14:52, 1 year 7 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research increases Cardiol Therapeutics Inc's price target to USD8.50 in Buy recommendation after positive results from phase II trial of CardiolRx for recurrent pericarditis treatment Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Phase II Trial CardiolRx
PRESS RELEASE published on 02/27/2024 at 14:16, 1 year 11 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024 FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRIEF published on 02/27/2024 at 14:16, 1 year 11 months ago Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRIEF published on 02/27/2024 at 14:16, 1 year 11 months ago Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
PRESS RELEASE published on 01/19/2024 at 12:41, 2 years ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided. Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
PRESS RELEASE published on 08/30/2023 at 15:06, 2 years 5 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 05/24/2023 at 13:01, 2 years 8 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 04/11/2023 at 15:26, 2 years 9 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
Published on 02/09/2026 at 13:00, 43 minutes ago Eagle Plains' Partner Refined Energy Corp. Mobilizes Geophysical Team to the Dufferin West Project, Saskatchewan
Published on 02/09/2026 at 13:00, 43 minutes ago Abasca Resources Announces Assay Results from the Summer 2025 Drill Program and Start of Winter Drilling at its Loki Flake Graphite Deposit
Published on 02/09/2026 at 13:00, 43 minutes ago ATHA Energy Provides Post CAD $63 Million Financing Plans - Focused on Growth and Discovery at the Angilak Uranium Project
Published on 02/09/2026 at 12:30, 1 hour 13 minutes ago Trans Canada Gold Corp. Grants Incentive Stock Options
Published on 02/09/2026 at 11:30, 2 hours 13 minutes ago FireFox Gold Expands the Northeast Zone, including 54.91 g/t Gold over 1.95 Metres in 95 Metre Step-out at Mustajärvi Gold Project, Finland
Published on 02/09/2026 at 13:35, 7 minutes ago DeFi Technologies launches the DEFT Valour Investment Opportunity Index
Published on 02/09/2026 at 13:32, 10 minutes ago Hapag-Lloyd publishes preliminary business figures for 2025
Published on 02/09/2026 at 11:45, 1 hour 57 minutes ago Ex-CBRE Paul Saville-King Appointed Group Chief Executive Officer at Unispace
Published on 02/09/2026 at 10:40, 3 hours 2 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 02/09/2026 at 08:30, 5 hours 13 minutes ago THERMADOR GROUPE : Plan to separate the roles of chairman and chief executive officer
Published on 02/09/2026 at 08:30, 5 hours 13 minutes ago THERMADOR GROUPE : Projet de séparation des mandats de président et directeur général
Published on 02/09/2026 at 08:00, 5 hours 43 minutes ago Eiffage renforce son expertise dans le secteur du froid industriel avec une prise de participation majoritaire dans l’entreprise française Quercy Réfrigération
Published on 02/09/2026 at 08:00, 5 hours 43 minutes ago Eiffage strengthen its expertise in the industrial refrigeration sector with the acquisition of a majority holding in the French company Quercy Réfrigération